Annual Revenue
$17.47 M
-$1.10 M-5.90%
December 31, 2023
Summary
- As of February 8, 2025, ICCC annual revenue is $17.47 million, with the most recent change of -$1.10 million (-5.90%) on December 31, 2023.
- During the last 3 years, ICCC annual revenue has risen by +$2.13 million (+13.88%).
- ICCC annual revenue is now -9.20% below its all-time high of $19.24 million, reached on December 31, 2021.
Performance
ICCC Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$6.01 M
+$538.70 K+9.84%
September 30, 2024
Summary
- As of February 8, 2025, ICCC quarterly revenue is $6.01 million, with the most recent change of +$538.70 thousand (+9.84%) on September 30, 2024.
- Over the past year, ICCC quarterly revenue has dropped by -$1.25 million (-17.17%).
- ICCC quarterly revenue is now -17.17% below its all-time high of $7.26 million, reached on March 31, 2024.
Performance
ICCC Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$23.84 M
+$615.10 K+2.65%
September 30, 2024
Summary
- As of February 8, 2025, ICCC TTM revenue is $23.84 million, with the most recent change of +$615.10 thousand (+2.65%) on September 30, 2024.
- Over the past year, ICCC TTM revenue has increased by +$2.56 million (+12.01%).
- ICCC TTM revenue is now at all-time high.
Performance
ICCC TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ICCC Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.9% | -17.2% | +12.0% |
3 y3 years | +13.9% | -17.2% | +12.0% |
5 y5 years | +59.0% | -17.2% | +12.0% |
ICCC Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -9.2% | at low | -17.2% | +74.4% | at high | +52.0% |
5 y | 5-year | -9.2% | +27.3% | -17.2% | +102.7% | at high | +73.7% |
alltime | all time | -9.2% | +694.2% | -17.2% | +1102.3% | at high | +3305.4% |
ImmuCell Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $6.01 M(+9.8%) | $23.84 M(+2.6%) |
Jun 2024 | - | $5.47 M(-24.6%) | $23.22 M(+9.1%) |
Mar 2024 | - | $7.26 M(+42.4%) | $21.28 M(+21.8%) |
Dec 2023 | $17.47 M(-5.9%) | $5.10 M(-5.6%) | $17.47 M(+7.3%) |
Sep 2023 | - | $5.40 M(+52.8%) | $16.29 M(+3.8%) |
Jun 2023 | - | $3.53 M(+2.5%) | $15.69 M(-2.1%) |
Mar 2023 | - | $3.45 M(-11.9%) | $16.01 M(-13.8%) |
Dec 2022 | $18.57 M(-3.5%) | $3.91 M(-18.5%) | $18.57 M(-7.6%) |
Sep 2022 | - | $4.80 M(+24.2%) | $20.10 M(-1.7%) |
Jun 2022 | - | $3.86 M(-35.6%) | $20.46 M(-3.2%) |
Mar 2022 | - | $6.00 M(+10.2%) | $21.14 M(+9.8%) |
Dec 2021 | $19.24 M(+25.4%) | $5.44 M(+5.7%) | $19.24 M(+9.7%) |
Sep 2021 | - | $5.15 M(+13.4%) | $17.54 M(+8.9%) |
Jun 2021 | - | $4.54 M(+10.6%) | $16.11 M(+10.8%) |
Mar 2021 | - | $4.11 M(+9.7%) | $14.54 M(-5.2%) |
Dec 2020 | $15.34 M(+11.8%) | $3.74 M(+0.6%) | $15.34 M(+0.7%) |
Sep 2020 | - | $3.72 M(+25.5%) | $15.23 M(+5.2%) |
Jun 2020 | - | $2.97 M(-39.6%) | $14.48 M(+1.8%) |
Mar 2020 | - | $4.91 M(+35.2%) | $14.22 M(+3.6%) |
Dec 2019 | $13.72 M(+24.9%) | $3.63 M(+22.3%) | $13.72 M(+5.3%) |
Sep 2019 | - | $2.97 M(+9.6%) | $13.03 M(+6.7%) |
Jun 2019 | - | $2.71 M(-38.6%) | $12.21 M(-2.4%) |
Mar 2019 | - | $4.41 M(+50.2%) | $12.52 M(+13.9%) |
Dec 2018 | $10.99 M(+5.3%) | $2.94 M(+36.4%) | $10.99 M(-1.8%) |
Sep 2018 | - | $2.15 M(-28.6%) | $11.18 M(+1.3%) |
Jun 2018 | - | $3.01 M(+4.6%) | $11.03 M(+12.9%) |
Mar 2018 | - | $2.88 M(-8.0%) | $9.77 M(-6.4%) |
Dec 2017 | $10.43 M(+9.3%) | $3.13 M(+56.2%) | $10.43 M(+9.7%) |
Sep 2017 | - | $2.00 M(+14.6%) | $9.51 M(+0.4%) |
Jun 2017 | - | $1.75 M(-50.6%) | $9.48 M(-6.2%) |
Mar 2017 | - | $3.54 M(+60.1%) | $10.10 M(+5.8%) |
Dec 2016 | $9.54 M(-6.7%) | $2.21 M(+12.5%) | $9.54 M(-4.8%) |
Sep 2016 | - | $1.97 M(-17.2%) | $10.02 M(-4.8%) |
Jun 2016 | - | $2.38 M(-20.4%) | $10.53 M(+4.1%) |
Mar 2016 | - | $2.99 M(+10.8%) | $10.11 M(-1.1%) |
Dec 2015 | $10.23 M(+34.6%) | $2.69 M(+9.0%) | $10.23 M(+5.0%) |
Sep 2015 | - | $2.47 M(+26.1%) | $9.74 M(+7.8%) |
Jun 2015 | - | $1.96 M(-36.8%) | $9.04 M(+4.9%) |
Mar 2015 | - | $3.10 M(+40.6%) | $8.62 M(+13.4%) |
Dec 2014 | $7.60 M(+26.5%) | $2.21 M(+24.6%) | $7.60 M(+9.3%) |
Sep 2014 | - | $1.77 M(+15.0%) | $6.95 M(+8.3%) |
Jun 2014 | - | $1.54 M(-26.0%) | $6.42 M(+2.8%) |
Mar 2014 | - | $2.08 M(+33.5%) | $6.24 M(+3.9%) |
Dec 2013 | $6.01 M(+11.5%) | $1.56 M(+26.3%) | $6.01 M(+2.4%) |
Sep 2013 | - | $1.23 M(-9.6%) | $5.87 M(+2.8%) |
Jun 2013 | - | $1.37 M(-26.0%) | $5.71 M(+3.5%) |
Mar 2013 | - | $1.85 M(+30.0%) | $5.52 M(+2.4%) |
Dec 2012 | $5.39 M(+5.5%) | $1.42 M(+32.0%) | $5.39 M(+2.2%) |
Sep 2012 | - | $1.08 M(-8.4%) | $5.27 M(+1.4%) |
Jun 2012 | - | $1.18 M(-31.6%) | $5.20 M(-1.4%) |
Mar 2012 | - | $1.72 M(+31.6%) | $5.27 M(+3.2%) |
Dec 2011 | $5.11 M(+16.5%) | $1.30 M(+30.0%) | $5.11 M(+3.7%) |
Sep 2011 | - | $1.00 M(-19.6%) | $4.93 M(+2.7%) |
Jun 2011 | - | $1.25 M(-19.8%) | $4.80 M(+3.7%) |
Mar 2011 | - | $1.56 M(+38.5%) | $4.63 M(+5.6%) |
Dec 2010 | $4.39 M(-2.7%) | $1.12 M(+28.5%) | $4.39 M(+2.1%) |
Sep 2010 | - | $873.70 K(-18.9%) | $4.29 M(-3.1%) |
Jun 2010 | - | $1.08 M(-17.8%) | $4.43 M(+1.8%) |
Mar 2010 | - | $1.31 M(+27.2%) | $4.36 M(-3.3%) |
Dec 2009 | $4.51 M(-2.8%) | $1.03 M(+1.9%) | $4.51 M(-4.6%) |
Sep 2009 | - | $1.01 M(+1.0%) | $4.72 M(+1.9%) |
Jun 2009 | - | $1.00 M(-31.5%) | $4.63 M(+3.9%) |
Mar 2009 | - | $1.46 M(+17.1%) | $4.46 M(-3.8%) |
Dec 2008 | $4.63 M(-23.7%) | $1.25 M(+35.0%) | $4.63 M(-5.2%) |
Sep 2008 | - | $924.00 K(+11.8%) | $4.89 M(-17.1%) |
Jun 2008 | - | $826.30 K(-49.5%) | $5.90 M(-2.2%) |
Mar 2008 | - | $1.64 M(+8.8%) | $6.03 M(-0.7%) |
Dec 2007 | $6.07 M(+26.4%) | $1.50 M(-22.2%) | $6.07 M(+4.8%) |
Sep 2007 | - | $1.93 M(+101.4%) | $5.79 M(+14.6%) |
Jun 2007 | - | $959.10 K(-42.8%) | $5.05 M(+2.4%) |
Mar 2007 | - | $1.68 M(+37.0%) | $4.93 M(+2.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2006 | $4.80 M(-3.6%) | $1.22 M(+2.5%) | $4.80 M(-2.9%) |
Sep 2006 | - | $1.19 M(+41.7%) | $4.95 M(+3.3%) |
Jun 2006 | - | $841.60 K(-45.5%) | $4.79 M(-2.9%) |
Mar 2006 | - | $1.54 M(+12.8%) | $4.93 M(-1.1%) |
Dec 2005 | $4.98 M(+34.8%) | $1.37 M(+32.2%) | $4.98 M(+9.3%) |
Sep 2005 | - | $1.03 M(+5.2%) | $4.56 M(+4.3%) |
Jun 2005 | - | $983.80 K(-38.4%) | $4.37 M(+7.9%) |
Mar 2005 | - | $1.60 M(+69.1%) | $4.05 M(+9.6%) |
Dec 2004 | $3.70 M(+10.1%) | $943.70 K(+11.6%) | $3.70 M(+3.3%) |
Sep 2004 | - | $845.60 K(+27.1%) | $3.58 M(+1.6%) |
Jun 2004 | - | $665.50 K(-46.4%) | $3.52 M(+1.4%) |
Mar 2004 | - | $1.24 M(+50.5%) | $3.47 M(+3.4%) |
Dec 2003 | $3.36 M(-45.7%) | $824.80 K(+4.6%) | $3.36 M(-13.4%) |
Sep 2003 | - | $788.60 K(+27.9%) | $3.88 M(-13.3%) |
Jun 2003 | - | $616.70 K(-45.3%) | $4.47 M(-17.4%) |
Mar 2003 | - | $1.13 M(-16.2%) | $5.42 M(-11.2%) |
Dec 2002 | $6.18 M(-7.4%) | $1.35 M(-2.9%) | $6.10 M(-11.8%) |
Sep 2002 | - | $1.39 M(-11.0%) | $6.91 M(+1.6%) |
Jun 2002 | - | $1.56 M(-13.8%) | $6.80 M(-3.0%) |
Mar 2002 | - | $1.81 M(-16.5%) | $7.01 M(+5.0%) |
Dec 2001 | $6.68 M(+18.5%) | $2.16 M(+69.7%) | $6.68 M(+7.4%) |
Sep 2001 | - | $1.27 M(-27.9%) | $6.22 M(+3.4%) |
Jun 2001 | - | $1.77 M(+20.2%) | $6.01 M(+6.0%) |
Mar 2001 | - | $1.47 M(-13.7%) | $5.67 M(+0.7%) |
Dec 2000 | $5.64 M(+14.8%) | $1.70 M(+58.8%) | $5.64 M(+7.6%) |
Sep 2000 | - | $1.07 M(-24.9%) | $5.24 M(-1.6%) |
Jun 2000 | - | $1.43 M(-0.3%) | $5.32 M(+8.7%) |
Mar 2000 | - | $1.43 M(+9.9%) | $4.90 M(+0.7%) |
Dec 1999 | $4.91 M(+9.1%) | $1.30 M(+12.4%) | $4.86 M(+2.2%) |
Sep 1999 | - | $1.16 M(+15.9%) | $4.76 M(+1.3%) |
Jun 1999 | - | $1.00 M(-28.6%) | $4.70 M(+2.2%) |
Mar 1999 | - | $1.40 M(+16.7%) | $4.60 M(+2.2%) |
Dec 1998 | $4.50 M(-1.2%) | $1.20 M(+9.1%) | $4.50 M(-5.4%) |
Sep 1998 | - | $1.10 M(+22.2%) | $4.76 M(+2.1%) |
Jun 1998 | - | $900.00 K(-30.8%) | $4.66 M(+2.2%) |
Mar 1998 | - | $1.30 M(-10.8%) | $4.56 M(0.0%) |
Dec 1997 | $4.56 M(+3.6%) | $1.46 M(+45.7%) | $4.56 M(+1.3%) |
Sep 1997 | - | $1.00 M(+25.0%) | $4.50 M(+2.3%) |
Jun 1997 | - | $800.00 K(-38.5%) | $4.40 M(0.0%) |
Mar 1997 | - | $1.30 M(-7.1%) | $4.40 M(-2.2%) |
Dec 1996 | $4.40 M(-10.2%) | $1.40 M(+55.6%) | $4.50 M(+7.1%) |
Sep 1996 | - | $900.00 K(+12.5%) | $4.20 M(-6.7%) |
Jun 1996 | - | $800.00 K(-42.9%) | $4.50 M(-8.2%) |
Mar 1996 | - | $1.40 M(+27.3%) | $4.90 M(-2.0%) |
Dec 1995 | $4.90 M(+11.4%) | $1.10 M(-8.3%) | $5.00 M(+2.0%) |
Sep 1995 | - | $1.20 M(0.0%) | $4.90 M(+2.1%) |
Jun 1995 | - | $1.20 M(-20.0%) | $4.80 M(0.0%) |
Mar 1995 | - | $1.50 M(+50.0%) | $4.80 M(+9.1%) |
Dec 1994 | $4.40 M(+12.8%) | $1.00 M(-9.1%) | $4.40 M(+2.3%) |
Sep 1994 | - | $1.10 M(-8.3%) | $4.30 M(+4.9%) |
Jun 1994 | - | $1.20 M(+9.1%) | $4.10 M(+7.9%) |
Mar 1994 | - | $1.10 M(+22.2%) | $3.80 M(-2.6%) |
Dec 1993 | $3.90 M(+25.8%) | $900.00 K(0.0%) | $3.90 M(+2.6%) |
Sep 1993 | - | $900.00 K(0.0%) | $3.80 M(+5.6%) |
Jun 1993 | - | $900.00 K(-25.0%) | $3.60 M(+2.9%) |
Mar 1993 | - | $1.20 M(+50.0%) | $3.50 M(+12.9%) |
Dec 1992 | $3.10 M(+40.9%) | $800.00 K(+14.3%) | $3.10 M(+3.3%) |
Sep 1992 | - | $700.00 K(-12.5%) | $3.00 M(+7.1%) |
Jun 1992 | - | $800.00 K(0.0%) | $2.80 M(+7.7%) |
Mar 1992 | - | $800.00 K(+14.3%) | $2.60 M(+13.0%) |
Dec 1991 | $2.20 M(-26.7%) | $700.00 K(+40.0%) | $2.30 M(-11.5%) |
Sep 1991 | - | $500.00 K(-16.7%) | $2.60 M(-3.7%) |
Jun 1991 | - | $600.00 K(+20.0%) | $2.70 M(-3.6%) |
Mar 1991 | - | $500.00 K(-50.0%) | $2.80 M(-3.4%) |
Dec 1990 | $3.00 M(+7.1%) | $1.00 M(+66.7%) | $2.90 M(+7.4%) |
Sep 1990 | - | $600.00 K(-14.3%) | $2.70 M(-10.0%) |
Jun 1990 | - | $700.00 K(+16.7%) | $3.00 M(+7.1%) |
Mar 1990 | - | $600.00 K(-25.0%) | $2.80 M(-3.4%) |
Dec 1989 | $2.80 M | $800.00 K(-11.1%) | $2.90 M(+38.1%) |
Sep 1989 | - | $900.00 K(+80.0%) | $2.10 M(+75.0%) |
Jun 1989 | - | $500.00 K(-28.6%) | $1.20 M(+71.4%) |
Mar 1989 | - | $700.00 K | $700.00 K |
FAQ
- What is ImmuCell annual revenue?
- What is the all time high annual revenue for ImmuCell?
- What is ImmuCell annual revenue year-on-year change?
- What is ImmuCell quarterly revenue?
- What is the all time high quarterly revenue for ImmuCell?
- What is ImmuCell quarterly revenue year-on-year change?
- What is ImmuCell TTM revenue?
- What is the all time high TTM revenue for ImmuCell?
- What is ImmuCell TTM revenue year-on-year change?
What is ImmuCell annual revenue?
The current annual revenue of ICCC is $17.47 M
What is the all time high annual revenue for ImmuCell?
ImmuCell all-time high annual revenue is $19.24 M
What is ImmuCell annual revenue year-on-year change?
Over the past year, ICCC annual revenue has changed by -$1.10 M (-5.90%)
What is ImmuCell quarterly revenue?
The current quarterly revenue of ICCC is $6.01 M
What is the all time high quarterly revenue for ImmuCell?
ImmuCell all-time high quarterly revenue is $7.26 M
What is ImmuCell quarterly revenue year-on-year change?
Over the past year, ICCC quarterly revenue has changed by -$1.25 M (-17.17%)
What is ImmuCell TTM revenue?
The current TTM revenue of ICCC is $23.84 M
What is the all time high TTM revenue for ImmuCell?
ImmuCell all-time high TTM revenue is $23.84 M
What is ImmuCell TTM revenue year-on-year change?
Over the past year, ICCC TTM revenue has changed by +$2.56 M (+12.01%)